JP2019505785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019505785A5 JP2019505785A5 JP2018534930A JP2018534930A JP2019505785A5 JP 2019505785 A5 JP2019505785 A5 JP 2019505785A5 JP 2018534930 A JP2018534930 A JP 2018534930A JP 2018534930 A JP2018534930 A JP 2018534930A JP 2019505785 A5 JP2019505785 A5 JP 2019505785A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- antibody
- progastrin
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022013712A JP7363007B2 (ja) | 2015-12-31 | 2022-01-31 | 食道癌の検出および治療のための組成物および方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15307189 | 2015-12-31 | ||
| EP15307189.9 | 2015-12-31 | ||
| EP16305139 | 2016-02-05 | ||
| EP16305139.4 | 2016-02-05 | ||
| PCT/EP2017/050037 WO2017114976A1 (en) | 2015-12-31 | 2017-01-02 | Compositions and methods for detecting and treating esophageal cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022013712A Division JP7363007B2 (ja) | 2015-12-31 | 2022-01-31 | 食道癌の検出および治療のための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019505785A JP2019505785A (ja) | 2019-02-28 |
| JP2019505785A5 true JP2019505785A5 (https=) | 2020-02-20 |
| JP7018885B2 JP7018885B2 (ja) | 2022-02-14 |
Family
ID=57821946
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018534930A Active JP7018885B2 (ja) | 2015-12-31 | 2017-01-02 | 食道癌の検出および治療のための組成物および方法 |
| JP2022013712A Active JP7363007B2 (ja) | 2015-12-31 | 2022-01-31 | 食道癌の検出および治療のための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022013712A Active JP7363007B2 (ja) | 2015-12-31 | 2022-01-31 | 食道癌の検出および治療のための組成物および方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11789021B2 (https=) |
| EP (2) | EP3397967B1 (https=) |
| JP (2) | JP7018885B2 (https=) |
| KR (2) | KR102197478B1 (https=) |
| CN (1) | CN108700589A (https=) |
| AU (2) | AU2017204686B2 (https=) |
| BR (1) | BR112018013272A2 (https=) |
| CA (2) | CA3193481A1 (https=) |
| EA (1) | EA037032B1 (https=) |
| ES (2) | ES3003287T3 (https=) |
| PL (1) | PL3397967T3 (https=) |
| SG (1) | SG11201805263TA (https=) |
| WO (1) | WO2017114976A1 (https=) |
| ZA (1) | ZA201804142B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240018264A1 (en) * | 2015-12-31 | 2024-01-18 | Progastrine Et Cancers S.À R.L. | Compositions and methods for detecting and treating ovarian cancer |
| WO2019110662A1 (en) * | 2017-12-05 | 2019-06-13 | Progastrine Et Cancers S.À R.L. | Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer |
| JP7338128B2 (ja) | 2017-12-08 | 2023-09-05 | イー、シー、エス、ビオトラッカー、エス、エー、アール、エル | 癌診断における放射性標識プロガストリン |
| TW201940881A (zh) | 2018-01-26 | 2019-10-16 | 瑞士商Ｅｃｓ前胃泌激素公司 | 在癌症診斷中結合前胃泌激素檢測與其他癌症生物標記的技術 |
| EP3759492A1 (en) | 2018-02-27 | 2021-01-06 | ECS-Progastrin SA | Progastrin as a biomarker for immunotherapy |
| JP7449640B2 (ja) * | 2018-03-13 | 2024-03-14 | クレアティブ マイクロテック インコーポレイテッド | 循環細胞を用いて被検者における治療反応及び疾患の進行をモニターする方法 |
| KR102167078B1 (ko) * | 2019-07-19 | 2020-10-16 | (주)파즈코리아 | 혈액 샘플 이송 장치 |
| WO2021081498A1 (en) * | 2019-10-24 | 2021-04-29 | The Johns Hopkins University | Compositions and methods for detecting and treating esophageal cancer |
| JP7287532B2 (ja) * | 2020-08-04 | 2023-06-06 | 王子ホールディングス株式会社 | トイレットロール |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444887A (en) | 1979-12-10 | 1984-04-24 | Sloan-Kettering Institute | Process for making human antibody producing B-lymphocytes |
| US4716111A (en) | 1982-08-11 | 1987-12-29 | Trustees Of Boston University | Process for producing human antibodies |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8924581D0 (en) | 1989-11-01 | 1989-12-20 | Pa Consulting Services | Bleaching of hair |
| WO1996033735A1 (en) | 1995-04-27 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| DE69120146T2 (de) | 1990-01-12 | 1996-12-12 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| GB9014932D0 (en) | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
| EP0519596B1 (en) | 1991-05-17 | 2005-02-23 | Merck & Co. Inc. | A method for reducing the immunogenicity of antibody variable domains |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| JPH05244982A (ja) | 1991-12-06 | 1993-09-24 | Sumitomo Chem Co Ltd | 擬人化ｂ−ｂ１０ |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5916771A (en) | 1996-10-11 | 1999-06-29 | Abgenix, Inc. | Production of a multimeric protein by cell fusion method |
| CA2722378C (en) | 1996-12-03 | 2015-02-03 | Amgen Fremont Inc. | Human antibodies that bind tnf.alpha. |
| BRPI9809391B8 (pt) | 1997-04-14 | 2021-05-25 | Amgen Res Munich Gmbh | processo para a produção de um receptor de antígeno anti-humano, anticorpo humano e composição farmacêutica |
| US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| US20030021786A1 (en) * | 2001-07-09 | 2003-01-30 | Gevas Philip C. | Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| DK1794586T3 (da) * | 2004-09-22 | 2013-05-13 | Cancer Advances Inc | Monoklonale antistoffer til progastrin |
| JP2009529915A (ja) * | 2006-03-20 | 2009-08-27 | ゾーマ テクノロジー リミテッド | ガストリン物質に対して特異的なヒト抗体および方法 |
| US7854932B2 (en) * | 2006-12-19 | 2010-12-21 | The Board Of Regents Of The University Of Texas System | Immunogenic compositions comprising progastrin and uses thereof |
| US20110085986A1 (en) | 2009-10-13 | 2011-04-14 | Pomila Singh | Diagnosis and treatment of epithelial cancers using labeled/conjugated progastrin peptides |
| US9217032B2 (en) | 2010-01-08 | 2015-12-22 | Les Laboratoires Servier | Methods for treating colorectal cancer |
| US9487582B2 (en) | 2010-01-08 | 2016-11-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methods for treating pancreatic cancer |
| US8900817B2 (en) | 2010-01-08 | 2014-12-02 | Les Laboratories Servier | Progastrin and liver pathologies |
| JP5829672B2 (ja) | 2010-03-24 | 2015-12-09 | レ ラボラトワール セルヴィエ | 結腸直腸及び胃腸癌の予防 |
| US10533050B2 (en) | 2010-07-26 | 2020-01-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methods and compositions for liver cancer therapy |
| FI20145550A7 (fi) * | 2014-06-13 | 2015-12-14 | Biohit Oyj | Gastriini-17 käyttö biomarkkerina atrofiselle gastriitille ja usealle sen seurauksena kohonneelle riskille |
| WO2016066671A1 (en) * | 2014-10-29 | 2016-05-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for treating resistant cancers using progastrin inhibitors |
-
2017
- 2017-01-02 KR KR1020187020013A patent/KR102197478B1/ko active Active
- 2017-01-02 EA EA201891527A patent/EA037032B1/ru unknown
- 2017-01-02 US US16/067,208 patent/US11789021B2/en active Active
- 2017-01-02 SG SG11201805263TA patent/SG11201805263TA/en unknown
- 2017-01-02 ES ES20217589T patent/ES3003287T3/es active Active
- 2017-01-02 AU AU2017204686A patent/AU2017204686B2/en active Active
- 2017-01-02 CA CA3193481A patent/CA3193481A1/en active Pending
- 2017-01-02 CA CA3009785A patent/CA3009785A1/en active Pending
- 2017-01-02 EP EP17700483.5A patent/EP3397967B1/en active Active
- 2017-01-02 PL PL17700483T patent/PL3397967T3/pl unknown
- 2017-01-02 EP EP20217589.9A patent/EP3848709B1/en active Active
- 2017-01-02 KR KR1020207037405A patent/KR102430893B1/ko active Active
- 2017-01-02 ES ES17700483T patent/ES2861587T3/es active Active
- 2017-01-02 WO PCT/EP2017/050037 patent/WO2017114976A1/en not_active Ceased
- 2017-01-02 BR BR112018013272-1A patent/BR112018013272A2/en not_active IP Right Cessation
- 2017-01-02 JP JP2018534930A patent/JP7018885B2/ja active Active
- 2017-01-02 CN CN201780013902.0A patent/CN108700589A/zh active Pending
-
2018
- 2018-06-20 ZA ZA201804142A patent/ZA201804142B/en unknown
-
2020
- 2020-03-31 AU AU2020202296A patent/AU2020202296B2/en active Active
-
2022
- 2022-01-31 JP JP2022013712A patent/JP7363007B2/ja active Active
-
2023
- 2023-09-15 US US18/468,096 patent/US20240085423A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230295300A1 (en) | Antibodies specific to delta 1 chain of t cell receptor | |
| JP2019505785A5 (https=) | ||
| JP7196076B2 (ja) | がんの処置のための抗ｔｎｆ関連アポトーシス誘発リガンド受容体２及び抗カドヘリン１７結合性二重特異的分子 | |
| EP2997042B1 (en) | Anti-cxcl1, cxcl7 and cxcl8 antibodies and their applications | |
| JP2019502923A5 (https=) | ||
| JP7301538B2 (ja) | リンパ球における阻害経路の中和 | |
| KR20210018311A (ko) | Dll3-cd3 이중 특이적 항체 | |
| EP4644425A1 (en) | Antibody that binds ErbB-2 and ErbB-3 | |
| KR20130043168A (ko) | 이원 가변 도메인 면역글로불린 및 이의 용도 | |
| AU2013355324A1 (en) | Blood-brain barrier (BBB) penetrating dual specific binding proteins | |
| JP2019505784A5 (https=) | ||
| US12516133B2 (en) | TGFβ/PD-L1 bispecific binding proteins | |
| CA3156983A1 (en) | Antibodies against the poliovirus receptor (pvr) and uses thereof | |
| JP2023547530A (ja) | 抗ｔｉｇｉｔ抗体およびその使用 | |
| WO2018067819A1 (en) | Compositions and methods for treatment of cancers | |
| US20250333506A1 (en) | Antibodies specific to delta 1 chain of t cell receptor | |
| KR20240150805A (ko) | Sting 효능제를 포함하는 항체 약물 접합체, 조합 및 사용 방법 | |
| CN116940597A (zh) | 多特异性抗体及其用途 | |
| JP2023528223A (ja) | 骨髄線維症を処置するための抗ヘモジュベリン（ｈｊｖ）抗体 | |
| US20240052065A1 (en) | Binding molecules for the treatment of cancer | |
| WO2024216028A1 (en) | Methods of treating cancer using an anti-ctla4 antibody and an enpp1 inhibitor | |
| KR20250169623A (ko) | 암 치료를 위한 grem1 길항제를 수반하는 조합 요법 | |
| US20220169736A1 (en) | Combinations of anti-ildr2 antibodies and pd-1 antagonists | |
| HK40117288A (zh) | 抗cd40抗体及其用途 |